Regenxbio Inc. (RGNX) PT Raised to $18 at Leerink
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Leerink raises RGNX PT to $18; current price $8.88; priceChangeSinceSignal 4.95.
Target: $18
Posted price: $8.88
Analyst firm: Leerink Partners
Analyst: Mani Foroohar
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.